BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/26/2024 1:28:46 PM | Browse: 364 | Download: 884
Publication Name World Journal of Gastroenterology
Manuscript ID 89562
Country Greece
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Immunotherapy of gastric cancer: Present status and future perspectives
Manuscript Source Invited Manuscript
All Author List John K Triantafillidis, Manousos M Konstadoulakis and Apostolos E Papalois
ORCID
Author(s) ORCID Number
John K Triantafillidis http://orcid.org/0000-0002-9115-232X
Manousos M Konstadoulakis http://orcid.org/0000-0002-9999-5022
Apostolos E Papalois http://orcid.org/0000-0001-8339-7426
Funding Agency and Grant Number
Corresponding Author Apostolos E Papalois, DPhil, Adjunct Professor, Unit of Surgical Research and Training, Second Department of Surgery, University of Athens, School of Medicine, Aretaieion Hospital, 76 Vas Sophias Avenue, Athens 11528, Attica, Greece. apostolospapalois@gmail.com
Key Words Gastric cancer; Chemotherapy; Immunotherapy; Immune checkpoint inhibitors; Bibliometrics; Scientometrics
Core Tip Gastric cancer (GC) remains a major cause of morbidity and mortality worldwide. Conservative treatment in the form of chemotherapy has recently made remarkable advances, particularly in the field of immunotherapy. Immunotherapy of GC represents one of the most important fields of research worldwide today, particularly in China, the United States, and Japan, as well as in some Western European countries. Several treatment regimens have been approved and are being implemented with satisfactory results. Also, several treatment regimens are currently under investigation, which are expected to improve the disappointing prognosis of this malignant neoplasm.
Publish Date 2024-02-26 13:28
Citation Triantafillidis JK, Konstadoulakis MM, Papalois AE. Immunotherapy of gastric cancer: Present status and future perspectives. World J Gastroenterol 2024; 30(8): 779-793
URL https://www.wjgnet.com/1007-9327/full/v30/i8/779.htm
DOI https://dx.doi.org/10.3748/wjg.v30.i8.779
Full Article (PDF) WJG-30-779-with-cover.pdf
Full Article (Word) WJG-30-779.docx